Compare Abeona Therapeutics Inc (ABEO) vs ARMOUR Residential REIT, Inc. (ARR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs ARMOUR Residential REIT, Inc. — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while ARMOUR Residential REIT, Inc. trades at $16.72 (market cap $2.07B). The key difference: ARMOUR Residential REIT, Inc. is far larger — about 4.9× Abeona Therapeutics Inc's market cap, and ARMOUR Residential REIT, Inc. pays a 17.28% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | ARR | |
|---|---|---|
Market Cap | $421.19M | $2.07B |
Sector | Health | Financials |
52-Week High | $7.45 | $19.12 |
52-Week Low | $4.17 | $14.05 |
Enterprise Value | $276.10M | — |
Dividend Yield | — | 17.28% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About ARMOUR Residential REIT, Inc.
ARMOUR Residential REIT Inc is a real estate investment trust that invests in residential mortgage-backed securities or RMBS. These are issued or guaranteed by U.S.-government-sponsored enterprises, such as Fannie Mae, Freddie Mac, or Ginnie Mae. The company's investment portfolio is composed of mortgage-backed securities, adjustable-rate mortgage securities, and multifamily mortgage-backed securities. In terms of total fair value, most Armour's investments are long-term, fixed-rate agency RMBS. Multifamily RMBS also represents a substantial amount. Fannie Mae guarantees most of the company's holdings. Armour derives substantially all its revenue as interest income from its investments.
Read more on ARR →
